Qelbree vs. Strattera: What’s the Difference?
Qelbree and Strattera are both non-stimulant ADHD medications, and both are options worth knowing about if a stimulant isn’t right for you — but they come from different drug classes and were approved years apart, with some real differences worth understanding.
What Strattera is
Strattera (atomoxetine) was the first non-stimulant specifically approved for ADHD, working as a selective norepinephrine reuptake inhibitor. It has a longer track record in clinical use, having been available for ADHD treatment for over two decades.
What Qelbree is
Qelbree (viloxazine) is a newer non-stimulant option, also acting on norepinephrine but through a different mechanism, approved more recently for both children and adults. As a newer option, it has a shorter real-world usage history, though its clinical trial data supported approval for ADHD specifically.
Key differences
- Approval history: Strattera has a longer track record; Qelbree is newer to the market
- Side effect profile: the two differ somewhat in common side effects, which your provider can walk through in detail
- Dosing: schedules and titration approaches differ between the two medications
- Individual response: as with most ADHD medications, some patients respond better to one than the other for reasons that aren’t fully predictable in advance
Why both matter as options
Having more than one non-stimulant option matters because not every patient tolerates or responds well to a single medication — if one doesn’t work out, having a genuinely different alternative (not just another stimulant) to try can make a real difference for patients who specifically need or prefer non-stimulant treatment.
What determines the right choice
Your provider will consider your specific symptoms, any co-occurring conditions, prior medication history, and side-effect tolerance when recommending a starting point between these — and either can be adjusted or switched if the first choice isn’t the right fit.
What to expect during the first few weeks on either one
Because both take time to build up in your system, it’s common to not notice much change immediately. Sticking with the trial period your provider recommends, rather than judging effectiveness after just a few days, gives a more accurate picture of whether the medication is actually working for you.
Talk to a provider about your options
If you haven’t been evaluated yet, take a free 2-minute screening and start the conversation with a licensed provider.
